Estimating factors related to fluoroquinolone resistance based on one health perspective: Static and dynamic panel data analyses from Europe
Frontiers in Pharmacology, ISSN: 1663-9812, Vol: 10, Page: 1145
2019
- 12Citations
- 31Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations12
- Citation Indexes12
- 12
- Captures31
- Readers31
- 31
Article Description
Objectives: Antimicrobial resistance (AMR) has become a One Health problem in which fluoroquinolone resistance has caused great concern. The aim of this study is to estimate factors related to fluoroquinolone resistance involving the professionals and antimicrobial consumption (AMC) in human and animal fields. Methods: A country-level panel data set in Europe from 2005 to 2016 was constructed. The dependent variables were measured by Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa) resistance rates to fluoroquinolones. Both the static and dynamic panel data models were employed to estimate the above factors associated with the resistance rates. Results: The 10% increase in the number of medical staff and veterinary professionals per 100,000 population were significantly correlated with the 32.44% decrease of P. aeruginosa and 0.57% decrease of E. coli resistance rates to fluoroquinolones (Coef. = -3.244, -0.057; p = 0.000, 0.030, respectively). The 10% increase in the human AMC was correlated with 10.06% and 8.04% increase of P. aeruginosa resistance rates to fluoroquinolones in static and dynamic models (Coef. = 1.006, 0.804; p = 0.006, 0.001, respectively). The 10% increase in veterinary AMC was related to a 1.65% decrease of P. aeruginosa resistance rates to fluoroquinolones (Coef. = -0.165, p = 0.019). Conclusions: The increases in medical and veterinary professionals are respectively associated with the decrease of P. aeruginosa and E. coli resistance rates to fluoroquinolones. The increase in human AMC is also associated with increase of P. aeruginosa resistance rates, while the increase in veterinary AMC was found to be associated with a decrease in resistance rate for P. aeruginosa.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85073771974&origin=inward; http://dx.doi.org/10.3389/fphar.2019.01145; http://www.ncbi.nlm.nih.gov/pubmed/31636561; https://www.frontiersin.org/article/10.3389/fphar.2019.01145/full; https://dx.doi.org/10.3389/fphar.2019.01145; https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2019.01145/full
Frontiers Media SA
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know